Development of a novel, fully human, anti-PCSK9 antibody with potent hypolipidemic activity by utilizing phage display-based strategy-Reference-Cited by-同舟云学术

Development of a novel, fully human, anti-PCSK9 antibody with potent hypolipidemic activity by utilizing phage display-based strategy

Published:2021-03 Issue: Volume:65 Page:103250
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Xu Menglong^ORCID,Lei Gaoxin,Chen Manman,Wang Ke,Lv Wenxiu,Zhang Panpan,Hu Tuo,Gao Jie,Lu Chenchen,Mei Ying,Xu Zhipan,Bai Zhengli,Hu Huajing,Jiang Yiwei,Tan Shuhua^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference88 articles.

1. Heart disease and stroke statistics-2019 update: a report from the American heart association;Benjamin;Circulation.,2019

2. Statin safety and associated adverse events: a scientific statement from the American heart association;Newman;Arterioscler Thromb Vasc Biol,2019

3. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation;Seidah;Proc Natl Acad Sci United States Am,2003

4. Molecular basis for LDL receptor recognition by PCSK9;Kwon;Proc Natl Acad Sci United States Am,2008

5. Molecular characterization of proprotein convertase subtilisin/kexin type 9-mediated degradation of the LDLR;Wang;J Lipid Res,2012

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of in vitro stochastic and non-stochastic affinity maturation strategies for phage display derived monoclonal antibodies;International Journal of Biological Macromolecules;2024-10

2. Restoration of miR‐299‐3p promotes efferocytosis and ameliorates atherosclerosis via repressing CD47 in mice;The FASEB Journal;2024-08-08

3. Harnessing filamentous phages for enhanced stroke recovery;Frontiers in Immunology;2024-01-16

4. A novel fully human anti‐NT‐ANGPTL3 antibody from phage display library exhibits potent ApoB, TG, and LDL‐C lowering activities in hyperlipidemia mice;The FASEB Journal;2024-01-04

5. A fully human monoclonal antibody targeting Semaphorin 5A alleviates the progression of rheumatoid arthritis;Biomedicine & Pharmacotherapy;2023-12